UCB - Current Assets

Stock Price
239.00
Daily Change
-7.30 -2.96%
Monthly
-5.87%
Yearly
59.65%
Q2 Forecast
258.33

UCB reported EUR6.05B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Alcon AG USD 6.45B 116M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
Amarin USD 649.88M 21.55M Dec/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Orion EUR 1.41B 66.8M Mar/2026
Recordati EUR 1.71B 144.32M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
UCB EUR 6.05B 733M Dec/2025
Unibail Rodamco EUR 3.97B 1.09B Dec/2025